ZA955497B - Peptide derivatives of alpha-MSH-and their application - Google Patents

Peptide derivatives of alpha-MSH-and their application

Info

Publication number
ZA955497B
ZA955497B ZA955497A ZA955497A ZA955497B ZA 955497 B ZA955497 B ZA 955497B ZA 955497 A ZA955497 A ZA 955497A ZA 955497 A ZA955497 A ZA 955497A ZA 955497 B ZA955497 B ZA 955497B
Authority
ZA
South Africa
Prior art keywords
msh
alpha
application
peptide derivatives
peptide
Prior art date
Application number
ZA955497A
Inventor
Lucien Dussourd D Hinterland
Anne-Marie Pinel
Original Assignee
Inst Europeen Biolog Cellulair
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Europeen Biolog Cellulair filed Critical Inst Europeen Biolog Cellulair
Priority to ZA955497A priority Critical patent/ZA955497B/en
Publication of ZA955497B publication Critical patent/ZA955497B/en

Links

ZA955497A 1995-07-03 1995-07-03 Peptide derivatives of alpha-MSH-and their application ZA955497B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA955497A ZA955497B (en) 1995-07-03 1995-07-03 Peptide derivatives of alpha-MSH-and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA955497A ZA955497B (en) 1995-07-03 1995-07-03 Peptide derivatives of alpha-MSH-and their application

Publications (1)

Publication Number Publication Date
ZA955497B true ZA955497B (en) 1996-02-13

Family

ID=25585192

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955497A ZA955497B (en) 1995-07-03 1995-07-03 Peptide derivatives of alpha-MSH-and their application

Country Status (1)

Country Link
ZA (1) ZA955497B (en)

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL321326A1 (en) Derivative of guanidine
AU5893696A (en) Modification of polypeptides
PL313541A1 (en) Derivatives of quinazoline
PL323066A1 (en) Derivatives of quinazoline
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL338144A1 (en) Derivatives of dolastatin 15
IL118294A0 (en) Preparation of 4-aryl-piperidine derivatives
AU5893796A (en) Modification of polypeptides
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
IL122607A0 (en) Preparation of N-substituted 3-hydroxypyrazoles
PL325517A1 (en) Derivatives of benzothiazolone
PL327238A1 (en) Derivatives of cyclopeptides
IL123320A0 (en) Detection of hypoprathyroidism
EP0831878A4 (en) Novel peptide inhibitors of calmodulin
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
EP0850950A4 (en) Peptide derivatives
EP0861849A4 (en) Peptide derivatives
PL312544A1 (en) Derivatives of 4-marcaptobenzoyl guanidine
IL117786A (en) Preparation of alpha-bisoximes
HUT76555A (en) Derivatives of trans apovincaminic-acid-esters
IL118781A0 (en) Preparation of N-protected 4-ketoproline derivatives